Mylan Violated Mirapex Patent, Judge Rules
A federal judge has found that a Boehringer Ingelheim International GmbH patent was violated through Mylan Pharmaceuticals Inc.'s efforts to introduce a generic version of restless leg syndrome treatment Mirapex....To view the full article, register now.
Already a subscriber? Click here to view full article